Literature DB >> 15273971

Efficacy of tobacco dependence treatment in the context of a "smoke-free grounds" worksite policy: a case study.

Omowunmi Y O Osinubi1, Sharmila Sinha, Elisheva Rovner, Marla Perez-Lugo, Neetu J Jain, Kitaw Demissie, Maurice Goldman.   

Abstract

BACKGROUND: Smoking restrictions provide opportunities to modify smoking behavior. A large insurance company implemented a smoke-free grounds policy at two of their office complexes in January, 2000.
METHODS: This cohort study evaluated the impact of the smoke-free grounds policy on abstinence among 128 employees who participated in a tobacco dependence treatment program.
RESULTS: The overall quit rate at 6 months was 44.5%. The larger complex showed a trend for higher quit rates compared to the smaller complex (46.5 vs. 28.6%). Post-ban participants had higher quit rates than pre-ban participants (52.4 vs. 43.0%). The probability of abstinence at 6 months follow-up was higher for post-ban compared to pre-ban participants (P = 0.03). Post-ban participants were 80% less likely to relapse than pre-ban participants. Non-quitters decreased their consumption by 6.6 cigarettes/day (39.1% decrease).
CONCLUSIONS: A "smoke-free grounds" policy encourages abstinence and may play a significant role in harm reduction among continuing tobacco users.

Entities:  

Mesh:

Year:  2004        PMID: 15273971     DOI: 10.1002/ajim.20020

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  9 in total

1.  Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association.

Authors:  Dariush Mozaffarian; Ashkan Afshin; Neal L Benowitz; Vera Bittner; Stephen R Daniels; Harold A Franch; David R Jacobs; William E Kraus; Penny M Kris-Etherton; Debra A Krummel; Barry M Popkin; Laurie P Whitsel; Neil A Zakai
Journal:  Circulation       Date:  2012-08-20       Impact factor: 29.690

2.  Effectiveness of Indiana's Statewide Smoke-Free Indoor Air Law in Reducing Prevalence of Adult Cigarette Smoking.

Authors:  Beom-Young Cho; Hsien-Chang Lin; Dong-Chul Seo
Journal:  J Prim Prev       Date:  2020-04

3.  Readiness for implementation of smoke-free work hours in private companies: A qualitative study of perceptions among middle managers.

Authors:  Lærke P Lidegaard; Maria Kristiansen; Charlotta Pisinger
Journal:  Tob Prev Cessat       Date:  2021-05-25

4.  Compliance monitoring of prohibition of smoking (under section-4 of COTPA) at a tertiary health-care institution in a smoke-free city of India.

Authors:  Jaya Prasad Tripathy; Sonu Goel; Binod Kumar Patro
Journal:  Lung India       Date:  2013-10

5.  Electronic Cigarettes on Hospital Campuses.

Authors:  Clare Meernik; Hannah M Baker; Karina Paci; Isaiah Fischer-Brown; Daniel Dunlap; Adam O Goldstein
Journal:  Int J Environ Res Public Health       Date:  2015-12-29       Impact factor: 3.390

6.  State adoption of 100% smoke-free acute non federal hospital campus policies.

Authors:  Adam O Goldstein; Julea Steiner; Anna McCullough; Kathryn D Kramer; Melva Fager Okun
Journal:  Int J Environ Res Public Health       Date:  2009-11-10       Impact factor: 3.390

7.  Development and introduction of a comprehensive tobacco control policy in a Canadian regional health authority.

Authors:  Diane Kunyk; Charl Els; Gerry Predy; Mary Haase
Journal:  Prev Chronic Dis       Date:  2007-03-15       Impact factor: 2.830

8.  Heavy smoking rate trends and related factors in Korean occupational groups: analysis of KNHANES 2007-2012 data.

Authors:  Bo-Guen Kim; Do-Dam Pang; Young-Jun Park; Jong-In Lee; Hyoung-Ryoul Kim; Jun-Pyo Myong; Tae-Won Jang
Journal:  BMJ Open       Date:  2015-11-12       Impact factor: 2.692

9.  Effects of a Tobacco-Free Work Site Policy on Employee Tobacco Attitudes and Behaviors, Travis County, Texas, 2010-2012.

Authors:  Sarah E Seidel; Kristi Metzger; Andrea Guerra; Jessie Patton-Levine; Sandeepkumar Singh; William T Wilson; Philip Huang
Journal:  Prev Chronic Dis       Date:  2017-12-14       Impact factor: 2.830

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.